Ferneau Philip has filed 4 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 90000 shares of Compass Therapeutics, Inc. ($CMPX) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Compass Therapeutics, Inc. | $CMPX | Ferneau Philip | Director | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 177,862,102 | 9999.99% | 0.05% |
| Feb. 11, 2025 | Compass Therapeutics, Inc. | $CMPX | Ferneau Philip | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Compass Therapeutics, Inc. | $CMPX | Ferneau Philip | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Compass Therapeutics, Inc. | $CMPX | Ferneau Philip | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |